Exactech Inc. (EXAC) Issues Q3 Earnings Guidance
Exactech Inc. (NASDAQ:EXAC) updated its third quarter earnings guidance on Monday. The company provided EPS guidance of $0.24-0.26 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.25, Analyst Ratings.Net reports. The company issued revenue guidance of $57.5-59.5 million, compared to the consensus revenue estimate of $58.64 million.Exactech also updated its FY14 guidance to $1.19-1.23 EPS.
Exactech Inc. (NASDAQ:EXAC) opened at 22.78 on Tuesday. Exactech Inc. has a 52 week low of $18.34 and a 52 week high of $26.52. The stock has a 50-day moving average of $24.62 and a 200-day moving average of $23.28. The company has a market cap of $311.1 million and a price-to-earnings ratio of 19.69.
Exactech (NASDAQ:EXAC) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.30 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.30. The company had revenue of $63.92 million for the quarter, compared to the consensus estimate of $63.80 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 5.4% on a year-over-year basis. Analysts expect that Exactech Inc. will post $1.21 EPS for the current fiscal year.
Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.
Stay on top of analysts' upgrades and downgrades with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' ratings changes. Register Now.